Monashee Investment Management »

Arcutis Biotherapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.8M 380k 9.91

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Aercap Holdings Nv SHS (AER)
Birkenstock Holding Com Shs (BIRK)
Ares Management Corporation Cl A Com Stk (ARES)
Dell Technologies CL C (DELL)
Corebridge Finl (CRBG)
Advanced Micro Devices (AMD)
Kenvue (KVUE)

View all positions for Monashee Investment Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Suvretta Capital Management
Rubric Capital Management
Frazier Life Sciences Management
BlackRock
Polar Capital Holdings
Vanguard Group
State Street Corporation
Franklin Resources
Gilder, Gagnon, Howe & Co
Morgan Stanley
Citadel Advisors
Cormorant Asset Management
Geode Capital Management
Ensign Peak Advisors

View all funds holding Arcutis Biotherapeutics